Physiological Effects of Hemodilution
Hemodilution improves blood flow but reduces oxygen-carrying capacity, with optimal oxygen delivery occurring at hematocrit levels of 28-30%, below which oxygen delivery begins to decline. 1
Mechanisms and Effects of Hemodilution
Blood Viscosity and Flow
- Hemodilution decreases whole-blood viscosity by reducing red cell aggregation and improving red cell deformability 1
- The reduced viscosity leads to increased blood flow velocity and improved microcirculation 2
- Cardiac output increases markedly to compensate for the decreased oxygen-carrying capacity 3
- Total peripheral resistance decreases progressively with hemodilution 4
Oxygen Delivery and Consumption
- As hematocrit is reduced, oxygen delivery increases up to 28-30%, but begins to decline at lower hematocrit levels 1
- The body maintains oxygen consumption through two compensatory mechanisms:
- A hematocrit level greater than 18% is needed to maintain systemic oxygen delivery and consumption during normothermic conditions 4
Cerebral Blood Flow and Oxygenation
- In cerebral infarction, cerebral autoregulatory mechanisms are impaired 1
- Hemodilution increases cerebral blood flow in both infarcted and contralateral hemispheres 1
- While there is an inverse relationship between hematocrit and cerebral blood flow, there is a linear relationship between hematocrit and oxygen delivery to brain tissue 1
- Maximal oxygen delivery to the brain occurs at hematocrit levels of 40-45%, challenging earlier beliefs that 30-33% was optimal 1
- PET scan studies in normal volunteers showed that despite increased cerebral blood flow with hemodilution, oxygen delivery to cerebral tissue still decreased 1
Organ-Specific Effects
- Hemodilution increases blood flow to all organs, improving tissue perfusion 6
- Surface tissue oxygenation on skeletal muscle and liver improves during hemodilution despite raised plasma viscosity 6
- The critical hematocrit value for the whole body may be higher than that required specifically for the brain 4
Clinical Implications and Limitations
Efficacy in Ischemic Conditions
- Hemodilution is particularly effective in increasing oxygenation in ischemic tissue (up to 66% increase in oxygen delivery) compared to normal conditions (only 5-15% increase) 2
- In stroke patients, hemodilution has been studied to improve cerebral blood flow to potentially viable brain tissue supplied by collaterals 1
- Despite theoretical benefits, clinical trials have not shown significant improvements in mortality or functional outcomes in stroke patients 1
Clinical Outcomes
- Hemodilution does not significantly reduce deaths within the first 4 weeks in stroke patients but may influence deaths within 3-6 months 1
- It has no significant influence on death, dependency, or institutionalization/long-term care 1
- Some trials showed a tendency toward reduction in deep venous thrombosis and pulmonary embolism at 3-6 months 1
- The risk of significant cardiac events does not increase with hemodilution 1
Limitations and Contraindications
- Intentional hemodilution, with or without venesection, is not recommended for treatment of patients with acute ischemic stroke (Class III, Level of Evidence A) 1
- The only possible exception for the use of hemodilution is in stroke patients with severe polycythemia 1
- Moderate hemodilution to hematocrit values of approximately 25% appears to be well tolerated even in single vessel coronary artery disease 3
Practical Considerations
- Maintenance of a normal circulating blood volume with regulation of metabolic parameters within physiological ranges is desirable 1
- Various solutions have been used for hemodilution including dextran 40, hydroxyethyl starch, and albumin 1
- Of the rheological factors influencing oxygen delivery, hematocrit plays the predominant role while plasma viscosity is of minor importance 6